These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 93625)

  • 1. Cerebral atrophy and long-term response to levodopa in Parkinson's disease.
    Schneider E; Fischer PA; Jacobi P; Becker H; Beyer M
    J Neurol; 1979; 222(1):37-43. PubMed ID: 93625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of cerebral atrophy for the symptomatology of Parkinson's disease.
    Schneider E; Fischer PA; Jacobi P; Becker H; Hacker H
    J Neurol Sci; 1979 Jul; 42(2):187-97. PubMed ID: 479910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features of brain atrophy in Parkinson's disease. A CT scan study.
    Steiner I; Gomori JM; Melamed E
    Neuroradiology; 1985; 27(2):158-60. PubMed ID: 3990948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa: long-term impact on Parkinson's disease.
    Br Med J (Clin Res Ed); 1981 Feb; 282(6262):417-8. PubMed ID: 6780051
    [No Abstract]   [Full Text] [Related]  

  • 5. Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa.
    Rascol O; Sabatini U; Chollet F; Fabre N; Senard JM; Montastruc JL; Celsis P; Marc-Vergnes JP; Rascol A
    J Neurol Neurosurg Psychiatry; 1994 May; 57(5):567-71. PubMed ID: 8201325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral atrophy in patients on long-term regular hemodialysis treatment.
    Savazzi GM; Cusmano F; Degasperi T
    Clin Nephrol; 1985 Feb; 23(2):89-95. PubMed ID: 3872759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between levodopa-independent symptoms and central atrophy evaluated by magnetic resonance imaging in Parkinson's disease.
    Durif F; Pollak P; Hommel M; Ardouin C; Le Bas JF; Crouzet G; Perret J
    Eur Neurol; 1992; 32(1):32-6. PubMed ID: 1563452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological correlates of brain atrophy in Parkinson's disease: a CT-scan study.
    Starkstein SE; Leiguarda R
    Mov Disord; 1993; 8(1):51-5. PubMed ID: 8419807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical and central atrophy in chronic schizophrenia. A controlled study.
    Okasha A; Madkour O
    Acta Psychiatr Scand; 1982 Jan; 65(1):29-34. PubMed ID: 7187173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological disturbances and cerebral atrophy determined by computerized tomography in parkinsonian patients with long-term levodopa treatment.
    Portin R; Raininko R; Rinne UK
    Adv Neurol; 1984; 40():219-27. PubMed ID: 6695598
    [No Abstract]   [Full Text] [Related]  

  • 11. Cortical atrophy in schizophrenia and mania: a comparative CT study.
    Nasrallah HA; McCalley-Whitters M; Jacoby CG
    J Clin Psychiatry; 1982 Nov; 43(11):439-41. PubMed ID: 7174617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemiparkinsonism-hemiatrophy syndrome.
    Ayromlou H; Najmi S; Arami MA
    Arch Iran Med; 2011 Mar; 14(2):152-4. PubMed ID: 21361726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computerized tomography of the brain in schizophrenic patients. A controlled study.
    Tanaka Y; Hazama H; Kawahara R; Kobayashi K
    Acta Psychiatr Scand; 1981 Mar; 63(3):191-7. PubMed ID: 6972151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography and aging: results in a normal elderly population.
    Laffey PA; Peyster RG; Nathan R; Haskin ME; McGinley JA
    Neuroradiology; 1984; 26(4):273-8. PubMed ID: 6462433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral atrophy in Parkinson's disease--represented in CT.
    Becker H; Schneider E; Hacker H; Fischer PA
    Arch Psychiatr Nervenkr (1970); 1979 Jul; 227(1):81-8. PubMed ID: 496619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between arteriosclerosis and cerebral atrophy in Parkinson's disease.
    Schneider E; Fischer PA; Becker H; Hacker H; Pencz A; Jacobi P
    J Neurol; 1977 Dec; 217(1):11-6. PubMed ID: 75248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrophy limited to the third ventricle in chronic schizophrenic patients. Report of a controlled series.
    Boronow J; Pickar D; Ninan PT; Roy A; Hommer D; Linnoila M; Paul SM
    Arch Gen Psychiatry; 1985 Mar; 42(3):266-71. PubMed ID: 2579616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders.
    Kobari M; Fukuuchi Y; Shinohara T; Obara K; Nogawa S
    J Neurol Sci; 1995 Feb; 128(2):212-8. PubMed ID: 7738597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease.
    Sapkota S; Gee M; Sabino J; Emery D; Camicioli R
    Mov Disord; 2014 Mar; 29(3):368-74. PubMed ID: 24395213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional cerebral blood flow in patients with Parkinson's disease under chronic levodopa therapy: measurements during "on" and "off" response fluctuations.
    Melamed E; Globus M; Mildworf B
    J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1301-4. PubMed ID: 3025375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.